Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Change in Accured Expenses (2023 - 2025)

Historic Change in Accured Expenses for Guardian Pharmacy Services (GRDN) over the last 3 years, with Q3 2025 value amounting to $2.0 million.

  • Guardian Pharmacy Services' Change in Accured Expenses rose 10984.87% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 5204.5%. This contributed to the annual value of -$11.1 million for FY2024, which is 15301.17% down from last year.
  • Per Guardian Pharmacy Services' latest filing, its Change in Accured Expenses stood at $2.0 million for Q3 2025, which was up 10984.87% from -$9.9 million recorded in Q2 2025.
  • Over the past 5 years, Guardian Pharmacy Services' Change in Accured Expenses peaked at $23.2 million during Q4 2023, and registered a low of -$20.7 million during Q3 2024.
  • Moreover, its 3-year median value for Change in Accured Expenses was $3.7 million (2024), whereas its average is $1.3 million.
  • Data for Guardian Pharmacy Services' Change in Accured Expenses shows a peak YoY increase of 17992.89% (in 2025) and a maximum YoY decrease of 18579.81% (in 2025) over the last 5 years.
  • Quarter analysis of 3 years shows Guardian Pharmacy Services' Change in Accured Expenses stood at $23.2 million in 2023, then tumbled by 77.0% to $5.3 million in 2024, then crashed by 61.91% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, -$9.9 million for Q2 2025, and $5.8 million during Q1 2025.